InsiderTrades.com logo
The Best AI Stock to Own in the World Today is Trading for Just $25
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him
Preston Klassen net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Preston Klassen Biography and Net Worth

CEO of Metacrine
Dr. Klassen has served as our President and Chief Executive Officer and as a member of our board of directors since June 2020. From March 2017 to June 2020, Dr. Klassen served as Executive Vice President, Head of Research and Development and Chief Medical Officer of Arena Pharmaceuticals, Inc. From June 2016 to March 2017, he was Chief Medical Officer of Laboratoris Sanifit S.L., a biotechnology company, and prior to that, from November 2009 to May 2016, was Executive Vice President, Head of Global Development at Orexigen Therapeutics, Inc. Dr. Klassen also held several positions of increasing responsibility at Amgen Inc., including Therapeutic Area Head for Nephrology. Before joining Amgen, he was a faculty member in the Division of Nephrology at Duke University Medical Center. Dr. Klassen holds a B.S. in Chemistry from Central University of Iowa. Dr. Klassen received his medical degree from the University of Nebraska College of Medicine and completed his residency in internal medicine, fellowship in nephrology, and Master of Health Sciences degree at Duke University.

What is Preston Klassen's net worth?

The estimated net worth of Preston Klassen is at least $315,063.57 as of January 26th, 2023. Dr. Klassen owns 541,905 shares of Metacrine stock worth more than $315,064 as of April 26th. This net worth estimate does not reflect any other investments that Dr. Klassen may own. Learn More about Preston Klassen's net worth.

How do I contact Preston Klassen?

The corporate mailing address for Dr. Klassen and other Metacrine executives is 3985 SORRENTO VALLEY BLVD. SUITE C, SAN DIEGO CA, 92121. Metacrine can also be reached via phone at 858-369-7800 and via email at [email protected]. Learn More on Preston Klassen's contact information.

Has Preston Klassen been buying or selling shares of Metacrine?

Preston Klassen has not been actively trading shares of Metacrine during the last ninety days. Most recently, Preston Klassen sold 380,605 shares of the business's stock in a transaction on Thursday, January 26th. The shares were sold at an average price of $0.41, for a transaction totalling $156,048.05. Following the completion of the sale, the chief executive officer now directly owns 541,905 shares of the company's stock, valued at $222,181.05. Learn More on Preston Klassen's trading history.

Who are Metacrine's active insiders?

Metacrine's insider roster includes Hubert Chen (Insider), Preston Klassen (CEO), and Paul Walker (Major Shareholder). Learn More on Metacrine's active insiders.

Preston Klassen Insider Trading History at Metacrine

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/26/2023Sell380,605$0.41$156,048.05541,905View SEC Filing Icon  
4/19/2022Sell44,748$0.50$22,374.00922,510View SEC Filing Icon  
5/20/2021Buy20,547$3.64$74,791.0820,547View SEC Filing Icon  
See Full Table

Preston Klassen Buying and Selling Activity at Metacrine

This chart shows Preston Klassen's buying and selling at Metacrine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Metacrine Company Overview

Metacrine logo
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.58
Low: $0.58
High: $0.59

50 Day Range

MA: $0.57
Low: $0.55
High: $0.59

2 Week Range

Now: $0.58
Low: $0.30
High: $0.59

Volume

83,889 shs

Average Volume

225,834 shs

Market Capitalization

$24.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
The Best AI Stock to Own in the World Today is Trading for Just $25
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him